SHC · Sotera Health Co
$18.89
-0.13 (-0.68%)
At close · Aug 14
Market Cap
$5.39B
Shares
285.37M
Sotera Health Co Earnings Call Transcripts
Every quarterly earnings call for Sotera Health Co (SHC) — the full transcript with speaker labels, the audio replay, AI call highlights and a management-tone score, plus the matching 8-K earnings release and the quarter's 10-Q or 10-K. Investor days and conferences appear here too.
Revenue & result across quarters
Revenue Net income YoY up YoY down artefacts
▲10%
$248.70M
$25.09M
'22 Q3
22-11-02
▲4.3%
$251.59M
−$408.00M
'22 Q4
23-01-09
▼6.8%
$220.59M
$2.84M
'23 Q1
23-05-03
▼4.3%
$255.28M
$23.51M
'23 Q2
23-08-03
▲5.8%
$263.18M
−$13.66M
'23 Q3
23-11-01
▲23.3%
$310.24M
$38.68M
'23 Q4
24-02-27
▲12.5%
$248.18M
$6.32M
'24 Q1
24-05-02
▲8.3%
$276.59M
$8.75M
'24 Q2
24-08-05
▲8.5%
$285.47M
$17.00M
'24 Q3
24-11-05
▼6.5%
$290.20M
$12.32M
'24 Q4
25-02-27
▲2.6%
$254.52M
−$13.26M
'25 Q1
25-05-01
▲6.4%
$294.34M
$7.96M
'25 Q2
25-08-08
▲9.1%
$311.31M
$48.40M
'25 Q3
25-11-04
▲4.6%
$303.44M
$34.85M
'25 Q4
26-02-24
▲10%
$280.05M
$26.59M
'26 Q1
26-05-05
LATEST
▲9.2%
$321.38M
$53.64M
'26 Q2
26-08-06
Earnings call
FY26 · Q2
2026-08-06
Sotera Health Q2 2026 Earnings Conference Call
Revenue
$321.38M
▲ 9.2% YoY Diluted EPS
$0.19
▲ 533.3% YoY Gross margin
55.4%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Conference
Investor event
2026-06-08
Goldman Sachs 47th Annual Global Healthcare Conference
No reported result — non-financial event
Audio
Transcript
Slides
Conference
Investor event
2026-06-03
2026 Jefferies Global Healthcare Conference
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY26 · Q1
2026-05-05
Sotera Health Co Q1 FY2026 Earnings Call
Confident tone
Sterigenics segment performance
Nelson Labs softness
Nordion Cobalt-60 harvest timing benefit
Revenue
$280.05M
▲ 10% YoY Diluted EPS
$0.09
Gross margin
52.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q4
2026-02-24
Sotera Health Co Q4 FY2025 Earnings Call
Confident tone
Sterigenics segment performance
Long-range plan execution and 2026 outlook
Nelson Labs
Revenue
$303.44M*
▲ 4.6% YoY Gross margin
54.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY25 · Q3
2025-11-04
Sotera Health Co Q3 FY2025 Earnings Call
Confident tone
Sterigenics performance
2025 guidance
Nelson Labs turnaround
Revenue
$311.31M
▲ 9.1% YoY Diluted EPS
$0.17
▲ 183.3% YoY Gross margin
57.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q2
2025-08-08
Sotera Health Co Q2 FY2025 Earnings Call
Confident tone
Sterigenics growth and volume recovery
Nelson Labs margin expansion
End market normalization / destocking
Revenue
$294.34M
▲ 6.4% YoY Diluted EPS
$0.03
▲ 0% YoY Gross margin
56.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q1
2025-05-01
Sotera Health Co Q1 FY2025 Earnings Call
Confident tone
Segment performance and growth
Sterigenics pricing
2025 guidance and outlook
Revenue
$254.52M
▲ 2.6% YoY Diluted EPS
$-0.05
▼ 350% YoY Gross margin
53.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q4
2025-02-27
Sotera Health Co Q4 FY2024 Earnings Call
Positive tone
Revenue and EBITDA growth
Nordion / cobalt-60 harvest timing
Tariff exposure and risk
Revenue
$290.20M*
▼ 6.5% YoY Gross margin
56.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY24 · Q3
2024-11-05
Sotera Health Co Q3 FY2024 Earnings Call
Positive tone
Sterigenics segment performance
Continuous glucose monitors / integrated solutions
Nelson Labs performance
Revenue
$285.47M
▲ 8.5% YoY Diluted EPS
$0.06
Gross margin
55.4%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q2
2024-08-05
Sotera Health Co Q2 FY2024 Earnings Call
Positive tone
Nordion Segment
Sterigenics Segment
Nelson Labs Segment
Revenue
$276.59M
▲ 8.3% YoY Diluted EPS
$0.03
▼ 62.5% YoY Gross margin
55.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q1
2024-05-02
Sotera Health Co Q1 FY2024 Earnings Call
Positive tone
Financial Results
Sterigenics Segment
Ethylene Oxide Litigation
Revenue
$248.18M
▲ 12.5% YoY Diluted EPS
$0.02
▲ 100% YoY Gross margin
51.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q4
2024-02-27
Sotera Health Co Q4 FY2023 Earnings Call
Positive tone
Nordion / Cobalt-60
Liquidity and leverage
Revenue and EBITDA growth
Revenue
$310.24M*
▲ 23.3% YoY Gross margin
58.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY23 · Q3
2023-11-01
Sotera Health Co Q3 FY2023 Earnings Call
Revenue
$263.18M
▲ 5.8% YoY Diluted EPS
$-0.05
▼ 155.6% YoY Gross margin
55.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q2
2023-08-03
Sotera Health Co Q2 FY2023 Earnings Call
Revenue
$255.28M
▼ 4.3% YoY Diluted EPS
$0.08
▼ 27.3% YoY Gross margin
54.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q1
2023-05-03
Sotera Health Co Q1 FY2023 Earnings Call
Revenue
$220.59M
▼ 6.8% YoY Diluted EPS
$0.01
▼ 90.9% YoY Gross margin
50.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q4
2023-01-09
Sotera Health Co Q4 FY2022 Earnings Call
Revenue
$251.59M*
▲ 4.3% YoY Gross margin
56.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY22 · Q3
2022-11-02
Sotera Health Co Q3 FY2022 Earnings Call
Revenue
$248.70M
▲ 10% YoY Diluted EPS
$0.09
▼ 10% YoY Gross margin
54.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q2
2022-08-04
Sotera Health Co Q2 FY2022 Earnings Call
Revenue
$266.64M
▲ 5.8% YoY Diluted EPS
$0.11
▼ 26.7% YoY Gross margin
56.4%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q1
2022-05-05
Sotera Health Co Q1 FY2022 Earnings Call
Revenue
$236.75M
▲ 11.6% YoY Diluted EPS
$0.11
▲ 175% YoY Gross margin
54.4%
Rev · 7q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q4
2022-03-01
Sotera Health Co Q4 FY2021 Earnings Call
Revenue
$241.25M*
▲ 11.3% YoY Gross margin
55.5%
Rev · 6q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY21 · Q3
2021-11-10
Sotera Health Co Q3 FY2021 Earnings Call
Revenue
$226.16M
▲ 13.1% YoY Diluted EPS
$0.10
Gross margin
55.5%
Rev · 6q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q2
2021-08-12
Sotera Health Co Q2 FY2021 Earnings Call
Revenue
$251.92M
▲ 18.2% YoY Diluted EPS
$0.15
▲ 400% YoY Gross margin
57.1%
Rev · 5q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q1
2021-05-13
Sotera Health Co Q1 FY2021 Earnings Call
Revenue
$212.15M
▲ 12.7% YoY Diluted EPS
$0.04
Gross margin
54.4%
Rev · 4q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q4
2021-01-11
Sotera Health Co Q4 FY2020 Earnings Call
Revenue
$216.84M*
Gross margin
55.6%
Rev · 3q
Audio
Transcript
Slides
8-K10-K
Showing 1–25 of 25 earnings calls
Key facts
CIK
1822479
CUSIP
83601L102
13F (30d)
304 filings
297 filers
Visit website
Investor relations